Imprivata (IMPR) Tops Q1 EPS by 7c, Q2, FY Guidance Falls Short

Imprivata (NYSE: IMPR) reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $25.6 million versus the consensus estimate of $24.55 million.

Imprivata sees Q2 2015 EPS of ($0.22)-($0.20), versus the consensus of ($0.14). Imprivata sees Q2 2015 revenue of $28.5-29.5 million, versus the consensus of $29.32 million.

Imprivata sees FY2015 EPS of ($0.59)-($0.52), versus the consensus of ($0.48). Imprivata sees FY2015 revenue of $123.5-126 million, versus the consensus of $121.75 million.

For earnings history and earnings-related data on Imprivata (IMPR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c